Sinovac Phase 3 Trial Results Expected Next Week
"); jQuery("#212 h3").html("
"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1565715_1_20201217054113.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1565715-20201217.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1565715-20201217.htm', 'DCS.dcsqry', '' ); } } }); }); });
2020-12-17 HKT 05:38
Share this story
Government adviser and respiratory medicine expert Dr David Hui said on Wednesday that he expected the phase 3 clinical trial results of the Sinovac coronavirus vaccine to be out on December 23.
The government announced last week that it had secured 7.5 million doses from the mainland firm as part of its procurement programme.
Dr Hui said if there were no problems with the trial results, the vaccine could be introduced here next month.
"At the moment Sinovac has published phase 1 and phase 2 data, showing the antibodies can develop in over 90 percent of the recipients," he said.
Dr Hui said that only when the company had good data would the vaccine be introduced in Hong Kong.
The government is making arrangements for three vaccines: Sinovac, Fosun BioNTech and Astrazeneca.
Dr Hui said the public wouldn't get to choose which vaccine they would get because this could lead to a shortage of one type of vaccine and a surplus of another.
He said any vaccine that was in surplus might therefore end up being wasted, as they have a shelf-life of about six months.
Ant Internationals Ant Bank And Bettr Selected For Hong Kongs GenAI Sandbox++
Digital bank Ant Bank and embedded financial solutions provider Bettr have been selected to participate in Hong Kong’... Read more
Visa And BOCHK Tapped For Hong Kong AI Sandbox To Test Agent-Initiated Commerce
Visa has announced that it is partnering with Bank of China (Hong Kong) (BOCHK) in the GenA.I. Sandbox++. With the Visa... Read more
Hong Kong Regulators Pick 36 Agentic AI Use Cases For GenA.I. Sandbox++
The Hong Kong Monetary Authority (HKMA), the Securities and Futures Commission (SFC), the Insurance Authority (IA), and... Read more
Finloop And Yunfeng Financial Become Latest Anchorpoint Authorised Distributors
Finloop and Yunfeng Financial have joined Anchorpoint’s HKDAP stablecoin beta access programme as authorised distribu... Read more
Standard Chartered Becomes First Bank To Distribute HKDAP Stablecoin
Standard Chartered Bank (Hong Kong) Limited (SCBHK) has become the first bank distributor of HKDAP, the Hong Kong dolla... Read more
Lianlian DigiTech Profit Doubles In H12026, Agent Wallet Pushes To Address Payment Needs
Lianlian DigiTech Co., Ltd, a payment service provider headquartered in China, reported its interim results for the fir... Read more